Anti-IL12/23IL-12/23JAK inhibitorsanti-TNFCrohn’s Disease
…50%). However, 79% required a 3rd line agent, most of which was Anti-IL12/23 (50%). 29% required a 4th line agent and 10% were on a 5th line…
5articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: JAK inhibitors ×
JAK inhibitors
This drug is selected. Its supporting articles are shown below.
Articles mentioning JAK inhibitors
5 articles · page 1 of 1JAKiJAK inhibitorsIBD-Control QuestionnaireInflammatory Bowel Disease Multidisciplinary UnitHospital Pharmacy DepartmentCrohn’s diseaseanti-TNF therapy
…als (Jan 2021–Sept 2024). Adult CD patients receiving biologics/JAKi were included. Clinical data (Harvey-Bradshaw Index (HBI), CRP,…
anti-IL-12/23JAK inhibitorsBTK inhibitorsanti-interferonanti-BAFFSLEsystemic lupus erythematosusCochrane
…aluating biologics (anti-BAFF, JAK inhibitors, anti-interferon, anti-IL-12/23, BTK inhibitors and T-cell modulators) in adult SLE patients. P…
JAK inhibitorscorticosteroid therapymonogenic lupusLupus nephritis
…. Most patients (n= 77, 87.5%) required corticosteroid therapy. JAK inhibitors were used in 29 patients (33%); response was complete in 3, par…
hydroxychloroquinerituximabJAK inhibitorsJAK inhibitorsmonogenic lupusintensive care interventionslupustertiary pediatric rheumatology centerlupus-likebiologic therapies+1 more
…C 2021 criteria, while nine met ILE criteria. During follow-up, hydroxychloroquine was used in 14 patients, csDMARDs in 9, JAK inhibitors in 10, a…